Glycopyrrolate Injection
Product Images NDC 71872-7289

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 71872-7289). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71872-7289.jpg (71872 7289)

Label for Glycopyrrolate Injection USP 4 mg/20 mL (0.2 mg/mL) multiple dose vial. The label indicates one vial per package, suitable for intramuscular or intravenous administration, containing benzyl alcohol as a preservative. Manufactured by Amneal Pharmaceuticals Pvt. Ltd., India, and repackaged and distributed by Medical Purchasing Solutions, Scottsdale, AZ.*

FDA Label Image

Structure (Glycopyrrolate Injection Usp 1)

Chemical structure of Glycopyrrolate showing the molecular arrangement including a bicyclic ring, ester linkage, and a quaternary ammonium group associated with a bromide ion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.